GeoVax Labs (GOVX) Stock Forecast, Price Target & Predictions
GOVX Stock Forecast
GeoVax Labs stock forecast is as follows: an average price target of $8.00 (represents a 206.51% upside from GOVX’s last price of $2.61) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
GOVX Price Target
The average price target for GeoVax Labs (GOVX) is $8.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $8.00 to $8.00. This represents a potential 206.51% upside from GOVX's last price of $2.61.
GOVX Analyst Ratings
According to 4 Wall Street analysts, GeoVax Labs's rating consensus is 'Buy'. The analyst rating breakdown for GOVX stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
GeoVax Labs Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 02, 2024 | Vernon Bernardino | H.C. Wainwright | $8.00 | $3.28 | 143.90% | 206.51% |
The latest GeoVax Labs stock forecast, released on Jul 02, 2024 by Vernon Bernardino from H.C. Wainwright, set a price target of $8.00, which represents a 143.90% increase from the stock price at the time of the forecast ($3.28), and a 206.51% increase from GOVX last price ($2.61).
GeoVax Labs Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $8.00 |
| Last Closing Price | $2.61 | $2.61 | $2.61 |
| Upside/Downside | -100.00% | -100.00% | 206.51% |
In the current month, the average price target of GeoVax Labs stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to GeoVax Labs's last price of $2.61. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 19, 2024 | Noble Capital Markets | Outperform | Outperform | Hold |
| Jul 23, 2024 | EF Hutton | - | Buy | Initialise |
| Jun 18, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| May 24, 2022 | Maxim Group | Buy | Buy | Hold |
GeoVax Labs's last stock rating was published by Noble Capital Markets on Aug 19, 2024. The company gave GOVX a "Outperform" rating, the same as its previous rate.
GeoVax Labs Financial Forecast
GeoVax Labs Revenue Forecast
| Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 20 | Dec 19 | Sep 19 | Jun 19 | Sep 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $251.62K | $268.51K | $333.21K | $209.94K | $638.00K |
| Avg Forecast | $41.70M | $37.23M | $35.75M | $34.26M | $514.37M | $12.83M | $12.32M | $11.80M | $1.93M | $1.93M | $1.93M | $1.93M | $1.76M | $1.33M | $300.68K | $400.00K | $300.00K | $300.00K | $300.00K | $638.00K |
| High Forecast | $42.67M | $38.10M | $36.58M | $35.05M | $526.33M | $13.13M | $12.60M | $12.08M | $1.98M | $1.98M | $1.98M | $1.98M | $1.82M | $1.37M | $300.68K | $400.00K | $300.00K | $300.00K | $300.00K | $765.60K |
| Low Forecast | $40.73M | $36.37M | $34.91M | $33.46M | $502.41M | $12.53M | $12.03M | $11.53M | $1.89M | $1.89M | $1.89M | $1.89M | $1.70M | $1.30M | $300.68K | $400.00K | $300.00K | $300.00K | $300.00K | $510.40K |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 13 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.63% | 0.90% | 1.11% | 0.70% | 1.00% |
GeoVax Labs's average Quarter revenue forecast for Jun 24 based on 1 analysts is $300.68K, with a low forecast of $300.68K, and a high forecast of $300.68K. GOVX's average Quarter revenue forecast represents a 19.50% increase compared to the company's last Quarter revenue of $251.62K (Dec 20).
GeoVax Labs EBITDA Forecast
| Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 20 | Dec 19 | Sep 19 | Jun 19 | Sep 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 13 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.32M | $-586.72K | $-421.48K | $-651.16K | $-273.37K |
| Avg Forecast | $-25.02M | $-22.34M | $-21.45M | $-20.55M | $-308.62M | $-7.70M | $-7.39M | $-7.08M | $-1.16M | $-1.16M | $-1.16M | $-1.16M | $-1.06M | $-801.00K | $-180.41K | $-240.00K | $-180.00K | $-180.00K | $-631.22K | $-364.49K |
| High Forecast | $-24.44M | $-21.82M | $-20.95M | $-20.08M | $-301.44M | $-7.52M | $-7.22M | $-6.92M | $-1.13M | $-1.13M | $-1.13M | $-1.13M | $-1.02M | $-782.37K | $-180.41K | $-240.00K | $-180.00K | $-180.00K | $-504.98K | $-291.59K |
| Low Forecast | $-25.60M | $-22.86M | $-21.95M | $-21.03M | $-315.80M | $-7.88M | $-7.56M | $-7.25M | $-1.19M | $-1.19M | $-1.19M | $-1.19M | $-1.09M | $-819.63K | $-180.41K | $-240.00K | $-180.00K | $-180.00K | $-757.47K | $-437.39K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.50% | 3.26% | 2.34% | 1.03% | 0.75% |
undefined analysts predict GOVX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than GeoVax Labs's previous annual EBITDA (undefined) of $NaN.
GeoVax Labs Net Income Forecast
| Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 20 | Dec 19 | Sep 19 | Jun 19 | Sep 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 13 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.34M | $-590.59K | $-424.43K | $-654.15K | $-296.78K |
| Avg Forecast | - | - | - | - | - | - | - | - | $-1.73M | $-1.86M | $-2.82M | $-3.11M | $-5.12M | $-8.43M | $-8.55M | $-1.52M | $-792.44B | $-1.23T | $-634.12K | $-395.70K |
| High Forecast | - | - | - | - | - | - | - | - | $-1.68M | $-1.80M | $-2.73M | $-3.01M | $-2.96M | $-8.17M | $-8.55M | $-1.52M | $-792.44B | $-1.23T | $-507.30K | $-316.56K |
| Low Forecast | - | - | - | - | - | - | - | - | $-1.78M | $-1.91M | $-2.90M | $-3.20M | $-8.57M | $-8.68M | $-8.55M | $-1.52M | $-792.44B | $-1.23T | $-760.95K | $-474.85K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.88% | 0.00% | 0.00% | 1.03% | 0.75% |
GeoVax Labs's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. GOVX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
GeoVax Labs SG&A Forecast
| Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 20 | Dec 19 | Sep 19 | Jun 19 | Sep 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 13 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $831.36K | $423.49K | $291.48K | $412.65K | $334.17K |
| Avg Forecast | $621.01M | $554.47M | $532.29M | $510.11M | $7.66B | $191.05M | $183.41M | $175.77M | $28.79M | $28.79M | $28.79M | $28.79M | $26.21M | $19.88M | $4.48M | $5.96M | $4.47M | $4.47M | $4.47M | $445.55K |
| High Forecast | $635.45M | $567.37M | $544.67M | $521.98M | $7.84B | $195.50M | $187.68M | $179.86M | $29.46M | $29.46M | $29.46M | $29.46M | $27.11M | $20.34M | $4.48M | $5.96M | $4.47M | $4.47M | $4.47M | $534.66K |
| Low Forecast | $606.57M | $541.58M | $519.91M | $498.25M | $7.48B | $186.61M | $179.15M | $171.68M | $28.12M | $28.12M | $28.12M | $28.12M | $25.30M | $19.42M | $4.48M | $5.96M | $4.47M | $4.47M | $4.47M | $356.44K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.14% | 0.09% | 0.07% | 0.09% | 0.75% |
GeoVax Labs's average Quarter SG&A projection for Jun 24 is $4.48M, based on 1 Wall Street analysts, with a range of $4.48M to $4.48M. The forecast indicates a 438.57% rise compared to GOVX last annual SG&A of $831.36K (Dec 20).
GeoVax Labs EPS Forecast
| Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 20 | Dec 19 | Sep 19 | Jun 19 | Sep 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 13 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.25 | $-2.52 | $-177.59 | $-32.71K | $-0.43 |
| Avg Forecast | - | - | - | - | - | - | - | - | $-0.27 | $-0.29 | $-0.44 | $-0.48 | $-0.80 | $-1.32 | $-3.37 | $-0.60 | $-312.00K | $-486.00K | $-588.00K | $-40.00K |
| High Forecast | - | - | - | - | - | - | - | - | $-0.26 | $-0.28 | $-0.43 | $-0.47 | $-0.46 | $-1.28 | $-3.37 | $-0.60 | $-312.00K | $-486.00K | $-588.00K | $-32.00K |
| Low Forecast | - | - | - | - | - | - | - | - | $-0.28 | $-0.30 | $-0.45 | $-0.50 | $-1.34 | $-1.36 | $-3.37 | $-0.60 | $-312.00K | $-486.00K | $-588.00K | $-48.00K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.42% | 0.00% | 0.00% | 0.06% | 0.00% |
According to undefined Wall Street analysts, GeoVax Labs's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to GOVX previous annual EPS of $NaN (undefined).
GeoVax Labs Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BWV | Onconetix | $0.18 | $4.00 | 2122.22% | Buy |
| ONTX | Traws Pharma | $1.00 | $7.00 | 600.00% | Buy |
| ATXI | Avenue Therapeutics | $2.01 | $12.00 | 497.01% | Buy |
| OCGN | Ocugen | $0.92 | $5.00 | 443.48% | Buy |
| ZURA | Zura Bio | $2.90 | $10.00 | 244.83% | Buy |
| GOVX | GeoVax Labs | $2.61 | $8.00 | 206.51% | Buy |
| EFTR | eFFECTOR Therapeutics | - | $5.50 | - | Buy |